GGrantIndex
Sort

30,917 grants matching tumor microenvironment

Mechanisms Underlying Functional Programs of Tumor-Associated Macrophages

$389,411
Scott I. Abrams · Roswell Park Cancer Institute Corp · R01 · FY2019 · CA

Targeting PPT1 in the Tumor Microenvironment

$389,391
Ravi K Amaravadi · Wistar Institute · P01 · FY2020 · CA

Immune Activating CAR-Modified Antigen Presenting Cells

$389,375
Carl Deselm · Washington University · DP5 · FY2018 · OD

Project 2: Optimal Targeting of the PD-1/PD-L1 Pathway in MRCC

$389,350
Catherine Ju-Ying Wu · Beth Israel Deaconess Medical Center · P50 · FY2023 · CA

METEOR Administrative Core

$389,345
Clifford Grant Robinson · Washington University · U54 · FY2025 · CA

Research Testbed 2

$389,324
David J Odde · University Of Minnesota · U54 · FY2023 · CA

Mechanisms of secondary injury after SCI

$389,250
Michael S. Beattie · University Of California, San Francisco · R01 · FY2014 · NS

Bioengineering approaches to map mechanotransduction in the living cell

$389,242
Ning Wang · University Of Illinois At Urbana-Champaign · R01 · FY2021 · GM

Project 1: Tumor Microenvironment Initiators of the Metastatic Cascade in High-Risk Prostate Cancer

$389,239
Joshua Michael Lang · University Of Wisconsin-Madison · P50 · FY2024 · CA

Linking Epigenetic-Therapy Induction of Inflammasome Signaling to Generation of a BRCAness Phenotype

$389,189
Kenneth P Nephew · Coriell Institute For Medical Research · P50 · FY2023 · CA

Linking Epigenetic-Therapy Induction of Inflammasome Signaling to Generation of a BRCAness Phenotype

$389,189
Kenneth P Nephew · Coriell Institute For Medical Research · P50 · FY2022 · CA

Arming Oncolytic HSV Vectors to Induce Anti-GBM Immune Responses in Syngeneic Mice

$389,162
Joseph C. Glorioso · University Of Pittsburgh At Pittsburgh · R01 · FY2022 · CA

Ex vivo culture platform validation for preservation of patient derived multiple myeloma cells

$389,121
Jenny Zilberberg · Hackensack University Medical Center · R33 · FY2018 · CA

Enlisting HPV integration events to illuminate drivers and target treatment in invasive cervical cancer

$389,114
Janet Rader · Medical College Of Wisconsin · R01 · FY2023 · CA

Subcellular enzyme-instructed self-assembly for molecular anticancer nanomedicines

$389,109
Bing Xu · Brandeis University · R01 · FY2022 · CA

Novobiocin-mediated polymerase theta inhibition in homologous recombination repair-deficient cancers

$389,092
Geoffrey I Shapiro · Dana-Farber Cancer Inst · R01 · FY2023 · CA

Epithelial Cell Mechanobiology in Mechanically Heterogeneous Microenvironments

$389,063
Amit Pathak · Washington University · R35 · FY2018 · GM

Synstatin Therapy for Multiple Myeloma

$389,053
Alan C Rapraeger · University Of Wisconsin-Madison · R01 · FY2012 · CA

Synstatin Therapy for Multiple Myeloma

$389,052
Alan C Rapraeger · University Of Wisconsin-Madison · R01 · FY2011 · CA

Bioengineering approaches to map mechanotransduction in the living cell

$389,025
Ning Wang · University Of Illinois At Urbana-Champaign · R01 · FY2022 · GM

Analyzing Adhesion and Signaling Functions for PTPN12 in Invasive Glioma Cells

$388,922
Joseph H McCarty · University Of Tx Md Anderson Can Ctr · R01 · FY2024 · NS

Targeting Oncogenic KRAS with Brush-Architectured Poly(ethylene glycol)-DNA Conjugates

$388,910
Ke Zhang · Northeastern University · R01 · FY2020 · CA

Interrogate the interaction between tumor cells and nerves in the tumor microenvironment of pancreatic cancer

$388,906
Lei Zheng · Johns Hopkins University · R01 · FY2020 · CA

Interrogate the interaction between tumor cells and nerves in the tumor microenvironment of pancreatic cancer

$388,906
Lei Zheng · Johns Hopkins University · R01 · FY2019 · CA

Interrogate the interaction between tumor cells and nerves in the tumor microenvironment of pancreatic cancer

$388,906
Lei Zheng · Johns Hopkins University · R01 · FY2021 · CA